XML 27 R16.htm IDEA: XBRL DOCUMENT
v3.24.2.u1

Derivative Instruments | 6 Months Ended
--- | ---
Jun. 30, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract] |
Derivative Instruments | 9. Derivative Instruments The Company manages risks associated with certain assets and liabilities by using derivative financial instruments. Derivative financial instruments are financial contracts whose value is derived from underlying interest rates, exchange rates or other financial instruments. The Company does not invest in derivatives for speculative purposes. Equity-indexed options are over-the-counter contractual agreements negotiated between counterparties. The Company purchases equity-indexed options as economic hedges against fluctuations in the equity markets to which equity-indexed products are exposed. Equity-indexed contracts include a fixed host universal-life insurance or annuity contract and an equity-indexed embedded derivative. The notional principal represents the amount to which a rate or price is applied to determine the cash flows to be exchanged periodically and does not represent credit exposure. Maximum credit risk is the estimated cost of replacing derivative financial instruments which have a positive value, should the counterparty default. Derivatives, except for embedded derivatives, are included in “Other invested assets”, at fair value in the Consolidated Statements of Financial Position. Embedded derivative liabilities on funds withheld and modified coinsurance (“Modco”) arrangements and embedded derivative liabilities on indexed annuity and variable annuity products are included in the Consolidated Statements of Financial Position within the “Reinsurance funds withheld” and “Policyholders’ account balances” lines respectively, at fair value. The notional and fair values of derivative instruments, presented in the Consolidated Statements of Financial Position, are shown below:
| Primary Underlying Risk | Location in the Consolidated Statements of Financial Position |  | June 30, 2024 |  | December 31, 2023
| Notional Amount |  | Carrying Value / Fair Value |  | Notional Amount |  | Carrying Value / Fair Value
|  | Assets |  | Liabilities |  |  | Assets |  | Liabilities
|  |  |  | (Dollars in millions)
Derivatives Not Designated as Hedging Instruments:
Equity-indexed options | Equity | Other invested assets, Other liabilities |  | $ | 45,871 |  |  | $ | 1,610 |  |  | $ | — |  |  | $ | 4,084 |  |  | $ | 227 |  |  | $ | — |
Embedded Derivatives: |  |  |  |  |  |  |  |  |  |  |  |  |  |
Indexed annuity and variable annuity product | Interest rate | Policyholders’ account balances |  | — |  |  | — |  |  | 1,196 |  |  | — |  |  | — |  |  | 873 |
Funds withheld and Modco arrangements | Interest rate | Funds withheld for reinsurance liabilities |  | — |  |  | — |  |  | 79 |  |  | — |  |  | — |  |  | — |
|  |  |  | $ | 45,871 |  |  | $ | 1,610 |  |  | $ | 1,275 |  |  | $ | 4,084 |  |  | $ | 227 |  |  | $ | 873 |
Derivatives Not Designated as Hedging Instruments The following represents the financial statement location and amount of gains (losses) related to the derivatives not designated as hedging instruments:
|  |  | Derivative Gains (Losses) Recognized in Income
|  |  | Three Months Ended June 30, |  | Six Months Ended June 30,
| Location in the Consolidated Statements of Operations |  | 2024 |  | 2023 |  | 2024 |  | 2023
|  |  | (Dollars in millions)
Equity-indexed options | Change in fair value of insurance-related derivatives and embedded derivatives |  | $ | 308 |  |  | $ | 46 |  |  | $ | 365 |  |  | $ | 71 |
Embedded derivatives: |  |  |  |  |  |  |  |  |
Indexed annuity and variable annuity product | Change in fair value of insurance-related derivatives and embedded derivatives |  | (250) |  |  | (20) |  |  | (288) |  |  | (71) |
Funds withheld and Modco arrangements | Change in fair value of insurance-related derivatives and embedded derivatives |  | (79) |  |  | — |  |  | (79) |  |  | — |
|  |  | $ | (21) |  |  | $ | 26 |  |  | $ | (2) |  |  | $ | — |
Derivative Exposure The Company’s use of derivative instruments exposes it to credit risk in the event of non-performance by counterparties. The Company has a policy of only dealing with counterparties it believes are creditworthy and obtaining sufficient collateral where appropriate, as a means to mitigating the financial loss from defaults. The Company holds collateral in cash and notes secured by U.S. government-backed assets. The non-performance risk is the net counterparty exposure based on fair value of open contracts less fair value of collateral held. The Company maintains master netting agreements with its current active trading partners. A right of offset has been applied to collateral that supports credit risk and has been recorded in the Consolidated Statements of Financial Position as an offset to “Other invested assets” with an associated payable to “Other liabilities” for excess collateral. A right of offset has also been applied to derivative assets and liabilities with the same counterparty under the same master netting agreement, and such derivative instruments are presented on a net basis in the Consolidated Statements of Financial Position. The fair value of our call options by counterparty and each counterparty's current credit rating are as follows:
|  |  |  |  |  |  |  | June 30, 2024 |  |  |  | December 31, 2023
Counterparty |  | Credit Rating (S&P) |  | Credit Rating (Moody's) |  |  |  | Fair Value |  |  |  | Fair Value
|  |  |  |  |  |  |  | (Dollars in millions)
Bank of America |  | A+ |  | Aa1 |  |  |  | $ | 162 |  |  |  |  | $ | 24 |
Barclays |  | A+ |  | A1 |  |  |  | 76 |  |  |  |  | 24 |
Canadian Imperial Bank of Commerce |  | A+ |  | Aa2 |  |  |  | 61 |  |  |  |  | — |
Citibank, N.A. |  | A+ |  | Aa3 |  |  |  | 46 |  |  |  |  | — |
Credit Suisse |  | A+ |  | Aa2 |  |  |  | 6 |  |  |  |  | 16 |
Goldman Sachs |  | A+ |  | A1 |  |  |  | 17 |  |  |  |  | — |
ING |  | A- |  | Baa1 |  |  |  | 6 |  |  |  |  | 10 |
J.P. Morgan |  | A+ |  | Aa2 |  |  |  | 149 |  |  |  |  | 12 |
Mizuho |  | A |  | A1 |  |  |  | 393 |  |  |  |  | — |
Morgan Stanley |  | A+ |  | Aa3 |  |  |  | 114 |  |  |  |  | 43 |
NATIXIS |  | A+ |  | A2 |  |  |  | 2 |  |  |  |  | 4 |
Royal Bank of Canada |  | AA- |  | A1 |  |  |  | 132 |  |  |  |  | — |
Societe Generale |  | A |  | A1 |  |  |  | 82 |  |  |  |  | — |
Truist |  | A |  | A3 |  |  |  | 119 |  |  |  |  | 59 |
UBS AG |  | A+ |  | Aa3 |  |  |  | 50 |  |  |  |  | — |
Wells Fargo |  | A+ |  | Aa2 |  |  |  | 195 |  |  |  |  | 35 |
|  |  |  |  |  |  |  | $ | 1,610 |  |  |  |  | $ | 227 |
Information regarding the Company’s exposure to credit loss on the derivatives it holds, including the effect of rights of offset, is presented below:
| Gross Amount of Derivative Instruments (1) |  | Gross Amount Offset in the Consolidated Statements of Financial Position |  | Net Amount Presented in the Consolidated Statements of Financial Position |  | Collateral (Received) Pledged in Cash (2) |  | Collateral (Received) Pledged in Invested Assets (2) |  | Exposure of Net Collateral
| (Dollars in millions)
As of June 30, 2024 |  |  |  |  |  |  |  |  |  |  |
Derivative assets |  |  |  |  |  |  |  |  |  |  |
Equity-indexed options | $ | 1,618 |  |  | $ | (8) |  |  | $ | 1,610 |  |  | $ | (1,587) |  |  | $ | (21) |  |  | $ | 2 |
Total derivative assets | $ | 1,618 |  |  | $ | (8) |  |  | $ | 1,610 |  |  | $ | (1,587) |  |  | $ | (21) |  |  | $ | 2 |
Derivative liabilities |  |  |  |  |  |  |  |  |  |  |
Equity-indexed options | $ | (8) |  |  | $ | 8 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |
Total derivative liabilities | $ | (8) |  |  | $ | 8 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |
As of December 31, 2023 |  |  |  |  |  |  |  |  |  |  |
Derivative assets |  |  |  |  |  |  |  |  |  |  |
Equity-indexed options | $ | 227 |  |  | $ | — |  |  | $ | 227 |  |  | $ | (205) |  |  | $ | (21) |  |  | $ | 1 |
Total derivative assets | $ | 227 |  |  | $ | — |  |  | $ | 227 |  |  | $ | (205) |  |  | $ | (21) |  |  | $ | 1 |
Derivative liabilities |  |  |  |  |  |  |  |  |  |  |
Equity-indexed options | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |
Total derivative liabilities | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |
(1)Represents derivative assets and liabilities on a gross basis, which are not offset under enforceable master netting agreements that meet all offsetting criteria. (2)Excludes a portion of collateral held in cash and invested assets that are excess collateral. As of June 30, 2024 and December 31, 2023, the Company held excess collateral of $52 million and $4 million, respectively.

X
- References No definition available. + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480237/815-40-50-5 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5C -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-5C Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 815 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/815/tableOfContent + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration